In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells

Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene

(2012) Carmela Guido et al.   CELL CYCLE

Epigallocatechin gallate affects survival and metabolism of human sperm

(2012) Francesca De Amicis et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38MAPK/CK2 signaling in human breast cancer cells

(2011) Francesca De Amicis et al.   FASEB JOURNAL

p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization

(2011) Junaid A. Khan et al.   MOLECULAR ENDOCRINOLOGY

Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo

(2010) Phan LCHB Tran et al.   BMC CANCER

Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer

(2010) Imtiaz A. Siddiqui et al.   FASEB JOURNAL

Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrestin Vivo

(2010) Bonnie Tillotson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Green tea consumption and breast cancer risk or recurrence: a meta-analysis

(2009) Adeyemi A. Ogunleye et al.   BREAST CANCER RESEARCH AND TREATMENT

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

(2009) Francesca De Amicis et al.   BREAST CANCER RESEARCH AND TREATMENT

Progesterone Receptor B Recruits a Repressor Complex to a Half-PRE Site of the Estrogen Receptor α Gene Promoter

(2009) F. De Amicis et al.   MOLECULAR ENDOCRINOLOGY

G Protein-Coupled Receptor 30 Expression Is Up-Regulated by EGF and TGFα in Estrogen Receptor α-Positive Cancer Cells

(2009) Adele Vivacqua et al.   MOLECULAR ENDOCRINOLOGY

(−)-Epigallocatechin-3-gallate Is a Novel Hsp90 Inhibitor†

(2008) Zhengyu Yin et al.   BIOCHEMISTRY